Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs

Eli Lilly and Co. LLY has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over the last month. Chart created using Benzinga ProLilly stock is well below its summer highs and is trading at $746.94 at the time of writing. The once red-hot obesity drugmaker is in the crosshairs of bearish technicals and political uncertainty.Could the selloff be an overreaction?Read Also: Eli Lilly, Verge Genomics Opt To Develop ALS Drug CandidateBearish Signals Galore For ...